Table 2.
Bivariable mortality analysis by myocardial infarction and percutaneous coronary intervention (N = 30,195,722).
| Ariables (%) | Mortality: 2,448,873 (8.11%) | Cost, median United States dollars ($) 29,143 (range 15,587–56,287) | Length of stay, median days 3 (range 2–5) | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| UA/NSTEMI: 2,155,975 (7.14%) | STEMI: 3,478,547 (11.52%) | UA/NSTEMI: $56,059 (29,194–106,095) | STEMI: $74,861 (46,585–122,465) | UA/NSTEMI: 4 (2–7) | STEMI: 3 (2–5) | |||||||||||||
| No PCI: 1,814,469 (84.16%) | PCI: 341,506 (15.84%) | P-value | No PCI: 1,946,595 (55.96%) | PCI: 1,531,952 (44.04%) | P-Value | No PCI: $39,618 (20,445–83,435) | PCI: $72,680 (44,663–123,811) | P-value | No PCI: $38,008 (18,144–89,103) | PCI: $81,960 (55,957–128,357) | P-value | No PCI: 4 (2–8) | PCI: 3 (2–7) | P-value | No PCI: 4 (2–8) | PCI: 3 (2–4) | P-value | |
| No cancer | 11.30 | 2.35 | <0.001 | 26.75 | 6.41 | <0.001 | 39,483 (20,232–83,797) | 72,608 (44,549–123,803) | <0.001 | 37,676 (17,780–90,558) | 81,959 (55,892–128,242) | <0.001 | 4 (2–8) | 3 (2–6) | <0.001 | 4 (2–8) | 3 (2–4) | <0.001 |
| Cancer | 13.32 | 3.02 | <0.001 | 32.12 | 8.90 | <0.001 | 40,406 (21,485–81,527) | 73,137 (45,496–123,817) | <0.001 | 39,688 (20,153–81,272) | 81,989 (56,660–129,395) | <0.001 | 5 (3–8) | 4 (2–7) | <0.001 | 4 (2–8) | 3 (2–5) | <0.001 |
| Breast | ||||||||||||||||||
| History | 9.84 | 1.73 | <0.001 | 27.57 | 8.24 | <0.001 | 37,036 (20,468–64,145) | 67,733 (41,300–111,708) | <0.001 | 33,348 (15,839–70,403) | 80,544 (57,881–119,920) | <0.001 | 4 (2–7) | 3 (2–6) | <0.001 | 4 (2–7) | 3 (2–5) | 0.062 |
| Active | 14.52 | 0.79 | <0.001 | 39.47 | 16.67 | 0.030 | 39,795 (20,321–76,507) | 73,325 (46,953–111,954) | <0.001 | 52,914 (27,204–118,261) | 77,385 (51,906–118,105) | 0.100 | 5 (2–8) | 4 (2–7) | 0.095 | 5 (3–12) | 3 (2–5) | 0.013 |
| Metastatic | 19.76 | 1.64 | <0.001 | 42.86 | 28.57 | 0.260 | 37,059 (22,154–74,875) | 85,280 (38,977–128,409) | <0.001 | 46,331 (24,845–113,660) | 81,841 (49,000–135,190) | 0.020 | 5 (2–8) | 4 (2–7) | 0.269 | 5 (3–11) | 4 (2–8) | 0.345 |
| Lung | <0.001 | <0.001 | ||||||||||||||||
| History | 11.30 | 3.57 | <0.001 | 31.58 | 11.39 | <0.001 | 38,672 (21,271–74,078) | 72,994 (47,883–112,613) | <0.001 | 34,548 (20,597–66,873) | 80,058 (57,488–135,796) | <0.001 | 5 (3–8) | 4 (2–6) | 0.006 | 4 (2–7) | 3 (2–6) | 0.549 |
| Active | 22.82 | 9.13 | <0.001 | 39.59 | 21.19 | <0.001 | 47,512 (24,626–91,404) | 74,196 (49,782–116,071) | <0.001 | 40,498 (19,516–78,998) | 99,581 (57,526–163,505) | <0.001 | 5 (3–9) | 5 (3–9) | 0.755 | 4 (2–8) | 4 (2–9) | 0.491 |
| Metastatic | 23.27 | 8.16 | 0.001 | 36.80 | 25.86 | 0.001 | 47,053 (24,626–88,410) | 77,798 (54,411–127,294) | <0.001 | 38,647 (16,107–75,284) | 97,537 (51,849–134,818) | <0.001 | 5 (3–9) | 5 (3–8) | 0.558 | 4 (2–8) | 4 (2–8) | 0.812 |
| Prostate | 0.144 | <0.001 | ||||||||||||||||
| History | 10.16 | 2.32 | <0.001 | 27.88 | 5.89 | <0.001 | 34,605 (19,043–68,583) | 74,589 (45,658–126,691) | <0.001 | 34,537 (16,899–67,835) | 79,883 (54,925–126,777) | <0.001 | 4 (2–7) | 3 (2–6) | <0.001 | 4 (2–7) | 3 (2–5) | 0.004 |
| Active | 13.59 | 3.45 | <0.001 | 34.67 | 8.08 | <0.001 | 39,712 (23,881–81,389) | 85,479 (50,212–142,427) | <0.001 | 40,704 (24,864–84,969) | 79,438 (55,561–137,324) | <0.001 | 5 (3–9) | 4 (2–8) | 0.007 | 6 (2–10) | 3 (2–7) | 0.004 |
| Metastatic | 14.84 | 4.08 | 0.004 | 31.03 | 18.75 | <0.001 | 43,516 (25,273–79,595) | 76,375 (47,744–137,167) | <0.001 | 32,685 (23,843–70,702) | 67,627 (55,648–117,526) | <0.001 | 5 (3–9) | 4 (2–9) | 0.060 | 4 (2–9) | 3 (2–6) | 0.272 |
| Colon | <0.001 | |||||||||||||||||
| History | 11.39 | 2.53 | <0.001 | 27.21 | 8.50 | <0.001 | 37,129 (20,418–72,128) | 72,120 (44,556–114,526) | <0.001 | 35,246 (15,955–64,534) | 81,350 (55,422–112,388) | <0.001 | 4 (3–8) | 4 (2–7) | <0.001 | 4 (2–7) | 3 (2–5) | 0.003 |
| Active | 18.58 | 6.06 | 0.003 | 30.00 | 19.35 | 0.288 | 76,802 (35,376–148,370) | 104,675 (55,870–183,304) | 0.002 | 50,822 (23,120–108,955) | 113,139 (64,982–175,087) | 0.005 | 8 (4–13) | 7 (3–12) | 0.070 | 5 (2–12) | 5 (2–15) | 0.643 |
| Metastatic | 18.23 | 6.12 | 0.037 | 32.43 | 8.70 | 0.035 | 51,511 (26,892–112,133) | 86,090 (50,970–174,804) | 0.005 | 49,372 (23,120–78,839) | 82,888 (64,982–175,087) | 0.002 | 6 (3–11) | 6 (2–10) | 0.482 | 5 (3–9) | 4 (2–14) | 0.789 |
| Skin | <0.001 | |||||||||||||||||
| History | 8.80 | 2.73 | <0.001 | 29.66 | 6.73 | <0.001 | 31832 (17,940–61,004) | 69,272 (43,558–110,059) | <0.001 | 36,652 (17,940–73,450) | 77,655 (53,331–117,858) | <0.001 | 4 (2–7) | 3 (2–6) | <0.001 | 4 (1–7) | 3 (2–4) | 0.115 |
| Active | 15.69 | 5.19 | 0.022 | 18.75 | 14.29 | 0.715 | 46,991 (21,979–91,548) | 84,049 (41,616–133,584) | <0.001 | 41,314 (27,015–75,622) | 87,643 (53,654–125,188) | 0.010 | 5 (3–10) | 4 (2–7) | 0.012 | 5 (3–6) | 2 (2–4) | 0.188 |
| Metastatic | 20.65 | 21.74 | 0.909 | 33.33 | 0.00 | 0.052 | 46,493 (21,381–83,185) | 97,682 (73,386–148,753) | <0.001 | 59,576 (30,926–79,217) | 91,565 (54,585–136,663) | 0.101 | 5 (2–8) | 7 (4–9) | 0.175 | 6 (3–10) | 5 (3–8) | 0.589 |
| Hematologic | <0.001 | |||||||||||||||||
| History | 11.58 | 3.45 | <0.001 | 18.75 | 7.10 | 0.011 | 36,401 (19,411–70,237) | 65,043 (41,059–121,736) | <0.001 | 40,818 (19,449–81,060) | 81,527 (53,788–121,246) | <0.001 | 4 (2–7) | 3 (2–6) | 0.002 | 4 (3–7) | 3 (2–5) | 0.004 |
| Active | 18.07 | 7.69 | <0.001 | 44.83 | 10.47 | <0.001 | 51,713 (26,013–118,492) | 85,932 (49,276–159,541) | <0.001 | 53,261 (24,470–147,175) | 99,786 (63,124–162,734) | <0.001 | 5 (3–11) | 5 (2–9) | 0.001 | 5 (2–13) | 3 (2–7) | 0.099 |
| Metastatic | 21.35 | 11.76 | 0.364 | 36.84 | 33.33 | 0.907 | 63,282 (29,464–135,134) | 81,999 (42,492–148,753) | 0.18 | 57,441 (36,396–128,357) | 59,088 (37,016–297,917) | 0.738 | 6 (3–12) | 6 (5–10) | 0.330 | 5 (3–11) | 3 (3–21) | 0.962 |
STEMI, ST segment elevation myocardial infarction, NSTEMI, non-ST segment elevation myocardial infarction; UA, unstable angina.